title: Clinical efficacy of α4 integrin block with natalizumab in ankylosing spondylitis.
authors.affiliation: Department of Rheumatology, University of Palermo, Palermo, Italy.
authors.forename: Francesco
authors.initials: F
authors.lastname: Ciccia
authors.affiliation: Department of Pathology, Azienda Ospedaliera Villa Sofia-Cervello, Palermo, Italy.
authors.forename: Aroldo
authors.initials: A
authors.lastname: Rizzo
authors.affiliation: Department of Rheumatology, University of Palermo, Palermo, Italy.
authors.forename: Giuliana
authors.initials: G
authors.lastname: Guggino
authors.affiliation: Department of Radiology, University of Palermo, Palermo, Italy.
authors.forename: Rodolfo
authors.initials: R
authors.lastname: Bignone
authors.affiliation: Department of Radiology, University of Palermo, Palermo, Italy.
authors.forename: Massimo
authors.initials: M
authors.lastname: Galia
authors.affiliation: Department of Rheumatology, University of Palermo, Palermo, Italy.
authors.forename: Giovanni
authors.initials: G
authors.lastname: Triolo
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001707:Biopsy, Needle; D005500:Follow-Up Studies; D006801:Humans; D007150:Immunohistochemistry; D039441:Integrin alpha4 / Q000187:drug effects* / Q000276:immunology; D008161:Lumbosacral Region; D008279:Magnetic Resonance Imaging / Q000379:methods; D008297:Male; D008875:Middle Aged; D058990:Molecular Targeted Therapy; D000069442:Natalizumab / Q000627:therapeutic use*; D011859:Radiography / Q000379:methods; D018570:Risk Assessment; D012720:Severity of Illness Index; D013167:Spondylitis, Ankylosing / Q000000981:diagnostic imaging* / Q000188:drug therapy* / Q000276:immunology; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D000069442:Natalizumab; D039441:Integrin alpha4
keywords: Inflammation; Spondyloarthritis; Treatment